药品:专业
阿根廷公司从事该行业的公司：药品:专业
下面的列表包含在同一行业，药品:专业下运营的阿根廷公司。该列表有助于跟踪他们的表现、损益表等。按任何必要的指标排序，它可以显示行业中最贵的股票，例如ASTRAZENECA PLC CEDEAR EACH REP 0.5 ADR USD0.25，或具有最佳价格动态的股票，例如PFIZER INC CEDEAR EACH 4 REP 1 ORD USD0.05，从而有助于设计任何重点策略。
商品代码 | 市值 | 价格 | 更改 % | 成交量 | 相对交易量 | P/E | 摊薄每股收益 净利率，TTM | 每股收益缓慢增长 TTM同比 | 股息收益率 % 净利率，TTM | 板块 | 分析师评级 |
|---|---|---|---|---|---|---|---|---|---|---|---|
 LLYDELI LILLY AND COMPANY CEDEAR EACH 56 REP 1 (USD)DR | 745.24 T ARS | 14.050 USD | +2.93% | 222 | 0.46 | 109.04 | 124.85 ARS | +178.70% | 0.34% | 健康科技 | — |
| LLYELI LILLY AND COMPANY CEDEAR EACH 56 REP 1 DR | 745.24 T ARS | 15,925.000 ARS | +2.58% | 8.89 K | 1.33 | 127.55 | 124.85 ARS | +564.33% | 0.34% | 健康科技 | — |
 JNJDJOHNSON & JOHNSON CEDEAR EACH 15 REP 1 ORD SHS(USD)DR | 355.65 T ARS | 9.790 USD | −1.51% | 561 | 0.23 | 30.91 | 306.92 ARS | +50.08% | 1.75% | 健康科技 | — |
| JNJJOHNSON & JOHNSON CEDEAR EACH 15 REP 1 ORD SHS DR | 355.65 T ARS | 11,150.000 ARS | +0.68% | 8.42 K | 0.19 | 36.33 | 306.92 ARS | +257.75% | 1.75% | 健康科技 | — |
| DJNJ3JOHNSON & JOHNSON CEDEAR(REPR 6.95% BDS) DR | 355.65 T ARS | 1,300.000 ARS | 0.00% | 15 | 1.90 | — | — | — | — | 健康科技 | — |
 ABBVDABBVIE INC CEDEAR EA 10 REP 1 COM(USD)DR | 317.25 T ARS | 17.900 USD | +1.70% | 70 | 0.50 | 7.40 | 2,343.37 ARS | +18.73% | 1.72% | 健康科技 | — |
| ABBVABBVIE INC CEDEAR EACH 10 REPR 1 COM DR | 317.25 T ARS | 20,375.000 ARS | +2.39% | 497 | 0.70 | 8.69 | 2,343.37 ARS | +183.01% | 1.72% | 健康科技 | — |
 MRKDMERCK & CO INC CEDEAR EAC 5 RE 1 (USD)DR | 253.61 T ARS | 20.600 USD | −4.19% | 31 | 0.56 | 22.60 | 883.37 ARS | +319.19% | 1.52% | 健康科技 | — |
| MRKMERCK & CO INC CEDEAR (5 REP 1 USD0.50) DR | 253.61 T ARS | 22,850.000 ARS | −0.22% | 1.07 K | 0.44 | 25.87 | 883.37 ARS | +899.22% | 1.52% | 健康科技 | — |
 AZNDASTRAZENECA PLC CEDEAR EA RE 0.5 ADR (USD)DR | 203.27 T ARS | 33.150 USD | +1.53% | 11 | 0.95 | 47.39 | 677.80 ARS | +64.44% | 1.51% | 健康科技 | — |
| AZNASTRAZENECA PLC CEDEAR EACH REP 0.5 ADR USD0.25 DR | 203.27 T ARS | 38,000.000 ARS | +2.01% | 373 | 0.23 | 56.06 | 677.80 ARS | +291.99% | 1.51% | 健康科技 | — |
 NVSDNOVARTIS AG CEDEAR EAC 4 REP 1(USD)DR | 195.36 T ARS | 25.000 USD | −11.97% | 2 | 1.05 | 2.79 | 8,672.72 ARS | +140.89% | 3.81% | 健康科技 | — |
| NVSNOVARTIS AG CEDEAR EACH 4 REP 1 DR | 195.36 T ARS | 28,275.000 ARS | +1.25% | 232 | 0.45 | 3.26 | 8,672.72 ARS | +474.20% | 3.81% | 健康科技 | — |
 PFEDPFIZER INC CEDEAR 4 REP 1 ORD USD0.05(USD)DR | 152.74 T ARS | 6.720 USD | +2.75% | 1.91 K | 0.67 | 27.74 | 234.71 ARS | +35.96% | 3.23% | 健康科技 | — |
| PFEPFIZER INC CEDEAR EACH 4 REP 1 ORD USD0.05 DR | 152.74 T ARS | 7,660.000 ARS | +3.51% | 27.81 K | 0.89 | 32.64 | 234.71 ARS | +224.10% | 3.23% | 健康科技 | — |
 BMYDBRISTOL-MYERS SQUIBB CO CEDEAR EACH 3 REP 1 USDDR | 118.89 T ARS | 20.600 USD | +0.98% | 5 | 0.56 | — | −1,078.84 ARS | −253.68% | 2.11% | 健康科技 | — |
| BMYBRISTOL-MYERS SQUIBB CO CEDEAR EACH 3 REP 1 DR | 118.89 T ARS | 21,875.000 ARS | +0.92% | 462 | 1.09 | — | −1,078.84 ARS | −466.33% | 2.11% | 健康科技 | — |
 GSKDGSK PLC CEDEAR EACH REPR 1/4 ADR (USD)DR | 68.86 T ARS | 8.750 USD | +0.11% | 6 | 0.06 | 27.54 | 307.84 ARS | −37.30% | 3.34% | 健康科技 | — |
| GSKGSK PLC CEDEAR EACH REPR 1/4 ADR DR | 68.86 T ARS | 9,860.000 ARS | +2.39% | 293 | 0.12 | 32.03 | 307.84 ARS | +49.45% | 3.34% | 健康科技 | — |
 BIIBDBIOGEN INC CEDEAR EAC 13 RE 1 COM(USD)DR | 21.82 T ARS | 11.450 USD | −3.78% | 2 | 0.15 | 15.95 | 695.64 ARS | +96.62% | 0.00% | 健康科技 | — |
| BIIBBIOGEN INC CEDEAR EACH 13 REP 1 COM USD0.0005 DR | 21.82 T ARS | 13,075.000 ARS | −0.19% | 241 | 0.28 | 18.80 | 695.64 ARS | +368.68% | 0.00% | 健康科技 | — |
 RICHLABORATORIOS RICHMOND SACIF | 140.91 B ARS | 1,745.000 ARS | +2.65% | 9.73 K | 0.67 | 18.12 | 96.29 ARS | — | 0.00% | 健康科技 | — |
 ROSEINSTITUTO ROSENBUCH SA DE BIOLOGIA | 5.11 B ARS | 120.000 ARS | 0.00% | 1.84 K | 0.18 | 28.11 | 4.27 ARS | +64.50% | 0.00% | 健康科技 | — |